The largest database of trusted experimental protocols

Vbit 4

Manufactured by Selleck Chemicals
Sourced in United States

The VBIT-4 is a compact and versatile laboratory equipment designed for various applications. It features four independent variable-speed stirring positions, allowing for simultaneous mixing of multiple samples. The device is equipped with a digital display that provides real-time monitoring of the stirring speed and duration. The VBIT-4 is a reliable and efficient tool for researchers and laboratory professionals.

Automatically generated - may contain errors

4 protocols using vbit 4

1

Ferroptosis Inducers and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Erastin (S7242) and RSL3 (S8155), Lip-1 (S7699), VBIT-4 (S3544), Mitoquinone mesylate (MitoQ, S8978), Decylubiquione (DecylQ, D7911) were purchased from Selleck Chemicals (Houston, TX, USA). Fer-1 (SML0583), Deferoxamine (DFO, D9533), Trolox (238813), z-VAD-FMK (V116), ML385 (SML1833), MitoTEMPO (SML0737) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Zileuton (3308) was from Tocris Bioscience (Bristol, UK). The following antibodies were used: GPx4 (ab125066, Abcam, Cambridge, UK) and Nrf2 (ab62352, Abcam), COXIV (4844, Cell signaling Technology, Danvers, MA, USA), FLAG (F3165, Sigma-Aldrich), α-tubulin (sc-8035, Santa Cruz, Dallas, TX, USA) and β-actin (sc-47778, Santa Cruz).
+ Open protocol
+ Expand
2

Isolation and Culture of Rat Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult cardiomyocytes were isolated from Sprague Dawley rats (200–250 g, male, Shanghai Jiesijie) according to the standard enzymatic technique as described previously [24 ]. In brief, the heart was excised quickly from anesthetized rat, cannulated through the ascending aorta, mounted on a Langendorff equipment, and perfused with oxygenated Krebs-Henseleit Buffer (KHB) with collagenase II (Worthington, Cat No. LS004177) and hyaluronidase (Sigma, Cat No. H3506) at 37 °C. After 20 min, the perfused heart was cut into small pieces and gently swirl in 37 °C water bath. Rod shaped cardiomyocytes were collected and plated on the coverslip with pre-coated laminin (Thermo Fisher, Cat No. 23017-015). Cardiomyocytes cultured in M199 medium (Sigma, Cat. No. M2520) with 5.5 mmol/L glucose as fuel, and supplemented with 10 mmol/L glutathione, 26.2 mmol/L sodium bicarbonate, 0.02% bovine serum albumin and 50 U/ml penicillin–streptomycin for 72 h to allow adequate gene expression. Attached cardiomyocytes were infected with Ad-Drp1, Ad-Drp1 C607A, Ad-GFP-Drp1, Ad-GFP-Drp1 C607A, Ad-mt-SoNar and Ad-mt-cpYFP at a multiplicity of infection of 50–100. ISO (Sigma, Cat. No. I0599990, 10 μmol/L) incubated for 48 h. VBIT-4 (Selleck, Cat. No. S3544, 10 μmol/L) incubated for 48 h.
+ Open protocol
+ Expand
3

Microglial Culture and Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated microglia were cultured in DMEM (Life Technologies) containing 10% (v/v) FCS, 1% (v/v) penicillin (100 IU ml−1)–streptomycin (100 μg ml−1), GlutaMAX (Thermo Fisher Scientific, 31331028), GM-CSF (50  ng ml−1, ImmunoTools, 12343123) and M-CSF (100 ng ml−1, ImmunoTools, 12343112). Cells were treated with H-151 (0.5 μM daily) or VBIT-4 (10 μM every other day, Selleckchem, S3544) for 4 days before gene expression analysis. The relative survival of primary microglia treated or not with H-151 (1 μM) was assessed 24 h after treatment using the CellTiter-Blue Cell Viability Assay (Promega, G808A), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Mitochondrial Protease Inhibition in iPSDM

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protease inhibitor cocktail (P1860-1ML, Sigma) was used at a 1:400 dilution and the inhibitor CA-074 methyl ester (CA-074 Me) (S7420, SelleckChem) was used at 50 μM. The proteasome inhibitor bortezomib was used at 5 nM. Unless otherwise specified, all the protease inhibitors were incubated simultaneously with the indicated treatments in X-VIVO 15 media.
Mitoprotease inhibitors treatment: the inhibitors 1,10-phenanthroline (o-Phe) (P9375-1G, Sigma), TPEN (P4413-50MG, Sigma) and A2-32-01 (CLpPi) (HY-111532, SelleckChem) were resuspended in DMSO and iPSDM pre-treated for 6 h using the following concentrations o-Phe (1 mM, 6 h); TPEN (0.2 mM) and A2-32-01 (CLpPi) (50 μM). After that, iPSDM were left untreated or treated with LLOMe (0.5 mM, 1 h) and samples processed for WB or mitochondrial membrane potential evaluation as described below.
VDAC1 and BAX oligomerization inhibitor treatment: iPSDM were pre-treated using the VDAC1 oligomerization inhibitor VBIT-4 (S3544, SelleckChem) at 10 μM for 6 h or the BAX oligomerisation inhibitor BAI (HY-103269, MedChemExpress) at 2 μM for 6 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!